Can VKORC1 help with Wechseljahre?

VKORC1 encodes vitamin K epoxide reductase, a key enzyme in the vitamin K cycle. Vitamin K activates proteins such as osteocalcin (bone health) and matrix Gla protein (vascular calcification). During menopause, the risk of osteoporosis and cardiovascular issues increases. In theory, a genetic variant in VKORC1 could affect vitamin K utilization and thus indirectly influence these risks. However, there are no direct studies linking VKORC1 to menopausal symptoms like hot flashes or mood changes. The evidence is purely mechanistic and speculative. Genetic testing for VKORC1 is not established for menopause management. Proven factors like calcium, vitamin D, exercise, and possibly hormone therapy are far more relevant. VKORC1 has a confirmed role in warfarin dosing, but not in menopausal symptoms.